SEC Tracker
Get the app

Amarin AMRN

New insider at David Paul Keenan

David Paul Keenan, new insider at AMRN

Form
3
Filed
Importance
Routine
  1. 7,950 American Depositary Shares directly owned.
  2. 6,740 Restricted Stock Units (shares paid out over time) granted on Feb 21, 2023.
  3. 5,000 Stock Options granted on Jun 1, 2022.

Written from the Form 3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Amarin files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Usana Health Sciences USNA public float $328M, Jun 27, 2025
  4. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  5. Altimmune ALT public float $327M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.